Endurance sport and cardiac injury

Kardiologia Polska

Volumn 72, Issue 7, 2014, Pages 587-597

  Leischik, Roman ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ENDURANCE SPORT; HEART FUNCTION; HEART INJURY; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE HYPERTROPHY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; REVIEW; SUDDEN CARDIAC DEATH; ATHLETIC INJURIES; DEATH, SUDDEN, CARDIAC; ENDURANCE; HEART INJURIES; PATHOLOGY; PHYSIOLOGY;

ATHLETIC INJURIES; DEATH, SUDDEN, CARDIAC; HEART INJURIES; HUMANS; PHYSICAL ENDURANCE;

EID: 84905656635     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: 10.5603/KP.a2014.0089     Document Type: Review

References (125)

1. Potts S. Marathon Battle of (490 BCE). The Encyclopedia of War. Wiley Online Library, 2011. Published Online 13 Nov. 2011 (http://onlinelibrary.wiley. com/doi/10.1002/9781444338232.wbeow389/abstract).
2. Frost F. The dubious origin of marathon. Am J Ancient History, 1979; 4: 159-163.
3. Marijon E, Tafflet M, Celermajer DS et al. Sports-related sudden death in the general population. Circulation, 2011; 124: 672-681.
4. Corrado D, Basso C, Rizzoli G et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol, 2003; 42: 1959-1963. (Pubitemid 37485572)
5. Priori SG, Aliot E, Blomstrom-Lundqvist C et al. Task Force on Sudden Cardiac Death, European Society of Cardiology. Europace, 2002; 4: 3-18. (Pubitemid 36124388)
6. World Health Organisation. World Health Report 2013 [available from: http://www.who.int/whr/2013/report/en/index.html].
7. Maron BJ, Thompson PD, Ackerman MJ et al. Recommendations and Considerations Related to Preparticipation Screening for Cardiovascular Abnormalities in Competitive Athletes: 2007 Update A Scientific Statement From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation. Circulation, 2007; 115: 1643-1655. (Pubitemid 46648650)
8. Solberg EE, Gjertsen F, Haugstad E et al. Sudden death in sports among young adults in Norway. Eur J Cardiovasc Prev Rehabil, 2010; 17: 337-341.
9. Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the evidence. CMAJ, 2006; 174: 801-809.
10. Mathews SC, Narotsky DL, Bernholt DL et al. Mortality among marathon runners in the United States, 2000-2009. Am J Sports Med, 2012; 40: 1495-1500.
11. Harris KM, Henry JT, Rohman E et al. Sudden death during the triathlon. JAMA, 2010; 303: 1255-1257.
12. Douglas PS, O'Toole ML, Hiller WD et al. Cardiac fatigue after prolonged exercise. Circulation, 1987; 76: 1206-1213. (Pubitemid 18007059)
13. Shave R, George K, Whyte G et al. Postexercise changes in left ventricular function: the evidence so far. Med Sci Sports Exerc, 2008; 40: 1393-1399.
14. Rifai N, Douglas PS, O'Toole M et al. Cardiac troponin T and I, echocardiographic [correction of electrocardiographic] wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon. Am J Cardiol, 1999; 83: 1085-1089. (Pubitemid 29162796)
15. Neilan TG, Januzzi JL, Lee-Lewandrowski E et al. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. Circulation, 2006; 114: 2325-2333. (Pubitemid 44847449)
16. Heidbuchel H, Hoogsteen J, Fagard R et al. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. Eur Heart J, 2003; 24: 1473-1480. (Pubitemid 37010576)
17. Heidbuchel H, La Gerche A. The right heart in athletes. Evidence for exercise-induced arrhythmogenic right ventricular cardiomyopathy. Herzschrittmacher Elektrophysiol, 2012; 23: 82-86.
18. Ector J, Ganame J, van der Merwe N et al. Reduced right ventricular ejection fraction in endurance athletes presenting with ventricular arrhythmias: a quantitative angiographic assessment. Eur Heart J, 2007; 28: 345-353.
19. La Gerche A, Burns AT, Mooney DJ et al. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J, 2012; 33: 998-1006.
20. Gajewski AK, Poznanska A. Mortality of top athletes, actors and clergy in Poland: 1924-2000 follow-up study of the long term effect of physical activity. Eur J Epidemiol, 2008; 23: 335-340.
21. Karvonen MJ, Klemola H, Virkajarvi J et al. Longevity of endurance skiers. Med Sci Sports, 1974; 6: 49-51.
22. Marijon E, Tafflet M, Antero-Jacquemin J et al. Mortality of French participants in the Tour de France (1947-2012). Eur Heart J, 2013; 34: 3145-3150.
23. Schnohr P, Marott JL, Lange P et al. Longevity in male and female joggers: the Copenhagen City Heart Study. Am J Epidemiol, 2013; 177: 683-689.
24. Mohlenkamp S, Leineweber K, Lehmann N et al. Coronary atherosclerosis burden, but not transient troponin elevation, predicts long-term outcome in recreational marathon runners. Basic Res Cardiol, 2014; 109: 391.
25. Oxborough D, Birch K, Shave R et al. "Exercise-induced cardiac fatigue": a review of the echocardiographic literature. Echocardiography, 2010; 27: 1130-1140.
26. Patterson SW, Starling EH On the mechanical factors which determine the output of the ventricles. J Physiol, 1914; 48: 357-379.
27. Braunwald E, Sonnenblick E, Ross J et al. An analysis of the cardiac response to exercise. Circ Res, 1967; 20: 44-58.
28. Saltin B, Stenberg J. Response to prolonged severe exercise. J Appl Physiol, 1964; 19: 833-838.
29. Fagard R. Athlete's heart. Heart, 2003; 89: 1455-1461. (Pubitemid 37465249)
30. George KP, Wolfe LA, Burggraf GW. The 'athletic heart syndrome'. A critical review. Sports Med, 1991; 11: 300-330.
31. Naylor LH, George K, O'Driscoll G et al. The athlete's heart: a contemporary appraisal of the 'Morganroth hypothesis'. Sports Med, 2008; 38: 69-90. (Pubitemid 350261960)
32. Henschen S. Skilanglauf und Skiwettlauf. Eine medizinische Sportstudie. Mitt Med Klin Upsala, 1899; 2: 74.
33. Dickhuth H, Hipp A, Niess A et al. Differenzialdiagnostik der physiologischen Herzhypertrophie (Sportherz). Deutsche Zeitschrift für Sportmedizin, 2001; 52: 205-210. (Pubitemid 33799737)
34. Morganroth J, Maron BJ, Henry WL et al. Comparative left ventricular dimensions in trained athletes. Ann Internal Med, 1975; 82: 521-524.
35. Hart G. Exercise-induced cardiac hypertrophy: a substrate for sudden death in athletes? Exp Physiol, 2003; 88: 639-644. (Pubitemid 37121738)
36. McCann GP, Muir DF, Hillis WS. Athletic left ventricular hypertrophy: long-term studies are required. Eur Heart J, 2000; 21: 351-253.
37. Shephard RJ. The athlete's heart: is big beautiful? Br J Sports Med, 1996; 30: 5-10. (Pubitemid 26088213)
38. Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation, 2006; 114: 1633-1644. (Pubitemid 44547434)
39. Drezner JA, Ackerman MJ, Cannon BC et al. Abnormal electrocardiographic findings in athletes: recognising changes suggestive of primary electrical disease. Br J Sports Med, 2013; 47: 153-167.
40. Pelliccia A. Filling the gap of understanding the athlete's ECG. Eur J Prev Cardiol, 2013; 20: 9-11.
41. Jost J, Weiss M, Weicker H. Comparison of sympatho-adrenergic regulation at rest and of the adrenoceptor system in swimmers, long-distance runners, weight lifters, wrestlers and untrained men. Eur J Appl Physiol Occup Physiol, 1989; 58: 596-604. (Pubitemid 19111879)
42. Costill DL, Fink WJ. Plasma volume changes following exercise and thermal dehydration. J Appl Physiol, 1974; 37: 521-525.
43. Laursen PB, Suriano R, Quod MJ et al. Core temperature and hydration status during an Ironman triathlon. Br J Sports Med, 2006; 40: 320-325; discussion 325.
44. Montain SJ, Coyle EF. Influence of graded dehydration on hyperthermia and cardiovascular drift during exercise. J Appl Physiol (1985), 1992; 73: 1340-1350.
45. Berger DS, Fellner SK, Robinson KA et al. Disparate effects of three types of extracellular acidosis on left ventricular function. Am J Physiol, 1999; 276: H582-H594. (Pubitemid 29100627)
46. Scheuer J, Stezoski SW Protective role of increased myocardial glycogen stores in cardiac anoxia in the rat. Circ Res, 1970; 27: 835-849.
47. Marzatico F, Pansarasa O, Bertorelli L et al. Blood free radical antioxidant enzymes and lipid peroxides following long-distance and lactacidemic performances in highly trained aerobic and sprint athletes. J Sports Med Phys Fitness, 1997; 37: 235-239. (Pubitemid 28062395)
48. Di Meo S, Venditti P. Mitochondria in exercise-induced oxidative stress. Neurosignals, 2001; 10: 125-140. (Pubitemid 32171163)
49. King DW, Gollnick PD. Ultrastructure of rat heart and liver after exhaustive exercise. Am J Physiology Legacy Content, 1970; 218: 1150-1155.
50. Sulkin NM, Sulkin DF. An electron microscopic study of the effects of chronic hypoxia on cardiac muscle, hepatic, and autonomic ganglion cells. Lab Invest, 1965; 14: 1523-1546.
51. Penpargkul S, Scheuer J. The effect of physical training upon the mechanical and metabolic performance of the rat heart. J Clin Invest, 1970; 49: 1859-1868.
52. Benito B, Gay-Jordi G, Serrano-Mollar A et al. Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation, 2011; 123: 13-22.
53. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol, 2008; 51: 802-809. (Pubitemid 351260071)
54. Whyte G, Sheppard M, George K et al. Post-mortem evidence of idiopathic left ventricular hypertrophy and idiopathic interstitial myocardial fibrosis: is exercise the cause? Br J Sports Med, 2008; 4: 304-305. (Pubitemid 351547696)
55. Rowe WJ. A world record marathon runner with silent ischemia without coronary atherosclerosis. Chest, 1991; 99: 1306-1308.
56. Wilson M, O'Hanlon R, Prasad S et al. Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J Appl Physiol (1985), 2011; 110: 1622-1626.
57. Breuckmann F, Mohlenkamp S, Nassenstein K et al. Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology, 2009; 251: 50-57.
58. Corrado D, Migliore F, Basso C et al. Exercise and the risk of sudden cardiac death. Herz, 2006; 31: 553-558. (Pubitemid 44579728)
59. Wike J, Kernan M. Sudden cardiac death in the active adult: causes, screening, and preventive strategies. Curr Sports Med Rep, 2005; 4: 76-82.
60. Erbel R, Budoff M. Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: the memory of lifetime risk factor exposure. Eur Heart J, 2012; 33: 1201-1213.
61. La Gerche A, Baggish AL, Knuuti J et al. Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death. J Am Coll Cardiol Cardiovasc Imag, 2013; 6: 993-1007.
62. Leischik R, Bartel T, Möhlenkamp S et al. Stress echocardiography: new techniques. Eur Heart J, 1997; 18: 49-56.
63. Leischik R, Dworrak B, Littwitz H et al. Prognostic significance of exercise stress echocardiography in 3329 outpatients (5-year longitudinal study). Int J Cardiol, 2007; 119: 297-305. (Pubitemid 46921249)
64. Greulich S, Schumm J, Grun S et al. Incremental value of late gadolinium enhancement for management of patients with hypertrophic cardiomyopathy. Am J Cardiol, 2012; 110: 1207-1212.
65. FoxBusiness. The True Costs of Training for Triathlons 2013 [available from: http://www.foxbusiness.com/personal-finance/2013/07/16/true-costs- training-for-triathlons/].
66. Leischik R. Ugly duckling or Nosferatu? Marathon running and cardiovascular function. How to screen the athletes? 2014 [available from: http://eurheartj.oxfordjournals.org/content/early/2014/01/08/eurheartj.eht502/ reply#ehj-el-2040].
67. Thiene G, Nava A, Corrado D et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med, 1988; 318: 129-133. (Pubitemid 18035134)
68. La Gerche A, Connelly KA, Mooney DJ et al. Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise. Heart, 2008; 94: 860-866. (Pubitemid 351914694)
69. Maron BJ, Gardin JM, Flack JM et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults Echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation, 1995; 92: 785-789.
70. Basavarajaiah S, Wilson M, Whyte G et al. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. J Am Coll Cardiol, 2008; 51: 1033-1039. (Pubitemid 351318133)
71. Lang RM, Bierig M, Devereux RB et al. Recommendations for chamber quantification. Eur J Echocardiography, 2006; 7: 79-108.
72. Haddad F, Hunt SA, Rosenthal DN et al. Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation, 2008; 117: 1436-1448. (Pubitemid 351501496)
73. D'Andrea A, Riegler L, Golia E et al. Range of right heart measurements in top-level athletes: the training impact. Int J Cardiol, 2013; 164: 48-57.
74. Grothues F, Moon JC, Bellenger NG et al. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J, 2004; 147: 218-223. (Pubitemid 38176819)
75. Simsek Z, Tas MH, Gunay E et al. Speckle-tracking echocardiographic imaging of the right ventricular systolic and diastolic parameters in chronic exercise. Int J Cardiovasc Imag, 2013; 29: 1265-1271.
76. Bray MS, Hagberg JM, Perusse L et al. The human gene map for performance and health-related fitness phenotypes: the 2006-2007 update. Med Sci Sports Exerc, 2009; 41: 35-73.
77. Wesslen L, Pahlson C, Lindquist O et al. An increase in sudden unexpected cardiac deaths among young Swedish orienteers during 1979-1992. Eur Heart J, 1996; 17: 902-910. (Pubitemid 26187180)
78. Knez WL, Coombes JS, Jenkins DG. Ultra-endurance exercise and oxidative damage: implications for cardiovascular health. Sports Med, 2006; 36: 429-441.
79. Clarkson PM, Thompson HS. Antioxidants: what role do they play in physical activity and health? Am J Clin Nutr, 2000; 72: 637-646.
80. Hassan MY, Noakes TD, Berlyn P et al. Preload maintenance protects against a depression in left ventricular systolic, but not diastolic, function immediately after ultraendurance exercise. Br J Sports Med, 2006; 40: 536-540. (Pubitemid 43886844)
81. Mueller SM, Anliker E, Knechtle P et al. Changes in body composition in triathletes during an Ironman race. Eur J Appl Physiol, 2013; 113: 2343-2352.
82. Mahler F, Ross J, Jr., O'Rourke RA et al. Effects of changes in preload, afterload and inotropic state on ejection and isovolumic phase measures of contractility in the conscious dog. Am J Cardiol, 1975; 35: 626-634.
83. Regwan S, Hulten EA, Martinho S et al. Marathon running as a cause of troponin elevation: a systematic review and meta-analysis. J Interv Cardiol, 2010; 23: 443-450.
84. Tulloh L, Robinson D, Patel A et al. Raised troponin T and echocardiographic abnormalities after prolonged strenuous exercise: the Australian Ironman Triathlon. Br J Sports Med, 2006; 40: 605-609. (Pubitemid 44032645)
85. Shave RE, Dawson E, Whyte G et al. Evidence of exercise-induced cardiac dysfunction and elevated cTnT in separate cohorts competing in an ultra-endurance mountain marathon race. Int J Sports Med, 2002; 23: 489-494. (Pubitemid 35398632)
86. Shave R, Oxborough D. Exercise-induced cardiac injury: evidence from novel imaging techniques and highly sensitive cardiac troponin assays. Prog Cardiovasc Dis, 2012; 54: 407-415.
87. Hart L Marathon-related cardiac arrest. Clin J Sport Med, 2013; 23: 409-410.
88. Mohlenkamp S, Lehmann N, Breuckmann F et al. Running: the risk of coronary events: prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J, 2008; 29: 1903-10.
89. Maron BJ. The Paradox of Exercise. N Engl J Med, 2000; 343: 1409-1411.
90. Yared K, Wood MJ. Is marathon running hazardous to your cardiovascular health? The jury is still out. Radiology, 2009; 251: 3-5.
91. Tanindi A, Cemri M. Troponin elevation in conditions other than acute coronary syndromes. Vasc Health Risk Manag, 2011; 7: 597-603.
92. Shave R, George KP, Atkinson G et al. Exercise-induced cardiac troponin T release: a meta-analysis. Med Sci Sports Exerc, 2007; 39: 2099-2106. (Pubitemid 350211502)
93. Mousavi N, Czarnecki A, Kumar K et al. Relation of biomarkers and cardiac magnetic resonance imaging after marathon running. Am J Cardiol, 2009; 103: 1467-72.
94. Leischik R, Spelsberg N, Littwitz H et al. Physiological Performance and Cardiac Function in Female Ironman-Triathletes. Am J Sports Science, 2014; 2: 41-47.
95. Marijon E, Bougouin W, Perier MC et al. Incidence of sports-related sudden death in France by specific sports and sex. JAMA, 2013; 310: 642-643.
96. Teramoto M, Bungum TJ. Mortality and longevity of elite athletes. J Sci Med Sport, 2010; 13: 410-416.
97. Sarna S, Sahi T, Koskenvuo M et al. Increased life expectancy of world class male athletes. Med Sci Sports Exerc, 1993; 25: 237-244. (Pubitemid 23061986)
98. Zwiers R, Zantvoord FWA, Engelaer FM et al. Mortality in former Olympic athletes: retrospective cohort analysis. BMJ, 2012; 345: e7456. Epub 2012.12.18.
99. Farahmand BY, Ahlbom A, Ekblom O et al. Mortality amongst participants in Vasaloppet: a classical long-distance ski race in Sweden. J Intern Med, 2003; 253: 276-283. (Pubitemid 36315198)
100. van Saase JL, Noteboom WM, Vandenbroucke JP Longevity of men capable of prolonged vigorous physical exercise: a 32 year follow up of 2259 participants in the Dutch eleven cities ice skating tour. BMJ, 1990; 301: 1409-1411.
101. Lee IM, Hsieh CC, Paffenbarger RS, Jr. Exercise intensity and longevity in men. The Harvard Alumni Health Study. JAMA, 1995; 273: 1179-1184.
102. Pelliccia A, Kinoshita N, Pisicchio C et al. Long-term clinical consequences of intense, uninterrupted endurance training in olympic athletes. J Am Coll Cardiol, 2010; 55: 1619-1625.
103. Blair SN, Connelly JC. How much physical activity should we do? The case for moderate amounts and intensities of physical activity. Res Q Exerc Sport, 1996; 67: 193-205. (Pubitemid 126421721)
104. Eaton S. Boyd, Eaton Stanley B. An evolutionary perspective on human physical activity: implications for health. Comparative Biochemistry and Physiology. Part A, 2003; 136: 153-159. (Pubitemid 37289414)
105. Lee IM, Skerrett PJ. Physical activity and all-cause mortality: what is the dose-response relation? Med Sci Sports Exerc, 2001; 33: 459-471; discussion 493-494.
106. Bellavia A, Bottai M, Wolk A et al. Physical activity and mortality in a prospective cohort of middle-aged and elderly men: a time perspective. Int J Behav Nutr Phys Act, 2013; 10: 94.
107. Calvo N, Brugada J, Sitges M et al. Atrial fibrillation and atrial flutter in athletes. Br J Sports Med, 2012; 46: 37-43.
108. Andersen K, Farahmand B, Ahlbom A et al. Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J, 2013; 34: 3624-3631.
109. Schultz MG, Otahal P, Cleland VJ et al. Exercise-induced hypertension, cardiovascular events, and mortality in patients undergoing exercise stress testing: a systematic review and meta-analysis. Am J Hypertens, 2013; 26: 357-366.
110. Gallagher MM, Camm J Classification of atrial fibrillation. Am J Cardiol, 1998; 82: 18-28.
111. Folkow B, Svanborg A. Physiology of cardiovascular aging. Physiol Rev, 1993; 73: 725-764. (Pubitemid 24004651)
112. Leischik R, Littwitz H. Slow recovery of the right and left ventricular deformation after conversion from atrial fibrillation. Am J Sports Science, 2014; 2: 13-16.
113. Scharhag J, Lollgen H, Kindermann W. Competitive sports and the heart: benefit or risk? Dtsch Arztebl Int, 2013; 110: 14-23.
114. O'Keefe JH, Harshal RP, Lavie CJ et al. Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc, 2012; 87: 587-595.
115. Herring MP, Sailors MH, Bray MS. Genetic factors in exercise adoption, adherence and obesity. Obes Rev, 2014; 15: 29-39.
116. Cerrone M, Priori SG Genetics of sudden death: focus on inherited channelopathies. Eur Heart J, 2011; 32: 2109-2118.
117. Leischik R, Spelsberg N. Kardiale und Leistungsdiagnostik bei Ironman-Triathleten - gibt es Hinweise für eine myokardiale Schädigung. Journal für Kardiologie - Austrian J Cardiol, 2014; 21: 144-152.
118. Jensen-Urstad K, Bouvier F, Saltin B et al. High prevalence of arrhythmias in elderly male athletes with a lifelong history of regular strenuous exercise. Heart, 1998; 79: 161-164. (Pubitemid 28157336)
119. Valsangiacomo Buechel ER, Mertens LL. Imaging the right heart: the use of integrated multimodality imaging. Eur Heart J, 2012; 33: 949-960.
120. Shave R, George K, Whyte G et al. A comparison of Doppler, tissue Doppler imaging, and strain rate imaging in the assessment of postexercise left ventricular function. Appl Physiol Nutr Metab, 2009; 34: 33-39.
121. Calvo N, Mont L, Tamborero D et al. Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes. Europace, 2010; 12: 30-36.
122. Zehender M, Meinertz T, Keul J et al. ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance. Am Heart J, 1990; 119: 1378-1391. (Pubitemid 20215625)
123. Baldesberger S, Bauersfeld U, Candinas R et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J, 2008; 29: 71-78.
124. Schnohr P. Longevity and causes of death in male athletic champions. Lancet, 1971; 2: 1364-1366.
125. Danaei G, Ding EL, Mozaffarian D et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med, 2009; 6: e1000058.